Assessment of Cost and Health Resource Utilization for Elderly Patients With Heart Failure and Diabetes Mellitus

Journal of Cardiac Failure

Volumn 16, Issue 6, 2010, Pages 454-460

  Bogner, Hillary R ^a   Miller, Steven D ^a   de Vries, Heather F ^a   Chhatre, Sumedha ^a   Jayadevappa, Ravishankar ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

cost; diabetes; health resource utilization; Heart failure

Indexed keywords

AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GERIATRIC PATIENT; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; REIMBURSEMENT; RETROSPECTIVE STUDY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; COSTS AND COST ANALYSIS; DIABETES MELLITUS; FEMALE; HEALTH CARE COSTS; HEALTH RESOURCES; HEART FAILURE; HUMANS; LENGTH OF STAY; MALE; MEDICARE; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; PENNSYLVANIA; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 77953609192     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2010.01.007     Document Type: Article

References (52)

1. Cohen-Solal A., Beauvais F., and Logeart D. Heart failure and diabetes mellitus: epidemiology and management of an alarming association. J Cardiac Failure 14 (2008) 615-625
2. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. [erratum appears in Circulation. 2007 Feb 6;115(5):e172]. Circulation 115 (2007) e69-171
3. Narayan K.M., Boyle J.P., Geiss L.S., Saaddine J.B., and Thompson T.J. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 29 (2006) 2114-2116
4. Shindler D.M., Kostis J.B., Yusuf S., Quinones M.A., Pitt B., Stewart D., et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol 77 (1996) 1017-1020
5. Zannad F., Briancon S., Juilliere Y., Mertes P.M., Villemot J.P., Alla F., et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine. J Am Coll Cardiol 33 (1999) 734-742
6. Cohen-Solal A., Desnos M., Delahaye F., Emeriau J.P., and Hanania G. A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society. Eur Heart J 21 (2000) 763-769
7. Yancy C.W., Lopatin M., Stevenson L.W., De Marco T., and Fonarow G.C. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 47 (2006) 76-84
8. Adams Jr. K.F., Fonarow G.C., Emerman C.L., LeJemtel T.H., Costanzo M.R., Abraham W.T., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 (2005) 209-216
9. Cleland J.G., Swedberg K., Follath F., Komajda M., Cohen-Solal A., Aguilar J.C., et al. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24 (2003) 442-463
10. Iribarren C., Karter A.J., Go A.S., Ferrara A., Liu J.Y., Sidney S., et al. Glycemic control and heart failure among adult patients with diabetes. Circulation 103 (2001) 2668-2673
11. Avendano G.F., Agarwal R.K., Bashey R.I., Lyons M.M., Soni B.J., Jyothirmayi G.N., et al. Effects of glucose intolerance on myocardial function and collagen-linked glycation. Diabetes 48 (1999) 1443-1447
12. de Groote P., Lamblin N., Mouquet F., Plichon D., McFadden E., Van Belle E., et al. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J 25 (2004) 656-662
13. Kannel W.B., and McGee D.L. Diabetes and cardiovascular disease. The Framingham study. JAMA 241 (1979) 2035-2038
14. Liu J., Masurekar M.R., Vatner D.E., Jyothirmayi G.N., Regan T.J., Vatner S.F., et al. Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart. Am J Physiol Heart Circ Physiol 285 (2003) H2587-H2591
15. Shindler D.M., Kostis J.B., Yusuf S., Quinones M.A., Pitt B., Stewart D., et al. Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registry. Am J Cardiol 77 (1996) 1017-1020
16. Nichols G.A., Gullion C.M., Koro C.E., Ephross S.A., and Brown J.B. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 27 (2004) 1879-1884
17. Held C., Gerstein H.C., Yusuf S., Zhao F., Hilbrich L., Anderson C., et al. Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation 115 (2007) 1371-1375
18. Dries D.L., Sweitzer N.K., Drazner M.H., Stevenson L.W., and Gersh B.J. Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol 38 (2001) 421-428
19. De Groote P., Lamblin N., Mouquet F., Plichon D., McFadden E., Van Belle E., et al. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J 25 (2004) 656-662
20. Domanski M., Krause-Steinrauf H., Deedwania P., Follmann D., Ghali J.K., Gilbert E., et al. The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. J Am Coll Cardiol 42 (2003) 914-922
21. Pocock S.J., Wang D., Pfeffer M.A., Yusuf S., McMurray J.J., Swedberg K.B., et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 27 (2006) 65-75
22. From A.M., Leibson C.L., Bursi F., Redfield M.M., Weston S.A., Jacobsen S.J., et al. Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med 119 (2006) 591-599
23. Varela-Roman A., Shamagian L.G., Caballero E.B., Ramos P.M., Veloso P.R., and Gonzalez-Juanatey J.R. Influence of diabetes on the survival of patients hospitalized with heart failure: a 12-year study. Eur J Heart Fail 7 (2005) 859-864
24. Andrews RM. The National Hospital Bill: the most expensive conditions by payer, 2006. HCUP Statistical Brief # 59 2008. Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb59.pdf.
25. Russo M.J., Gelijns A.C., Stevenson L.W., Sampat B., Aaronson K.D., Renlund D.G., et al. The cost of medical management in advanced heart failure during the final two years of life. [see comment]. J Cardiac Failure 14 (2008) 651-658
26. Masoudi F.A., Baillie C.A., Wang Y., Bradford W.D., Steiner J.F., Havranek E.P., et al. The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med 165 (2005) 2069-2076
27. Liao L., Allen L.A., and Whellan D.J. Economic burden of heart failure in the elderly. Pharmacoeconomics (2008) 26447-26462
28. Pelletier E.M., Smith P.J., Boye K.S., Misurski D.A., Tunis S.L., and Minshall M.E. Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research. Appl Health Econ Health Pol 6 (2008) 103-112
29. Brandle M., Zhou H., Smith B.R.K., Marriott D., Burke R., Tabaei B.P., et al. The direct medical cost of type 2 diabetes. Diabetes Care 26 (2003) 2300-2304
30. Ettaro L., Songer T.J., Zhang P., and Engelgau M.M. Cost-of-illness studies in diabetes mellitus. PharmacoEconomics 22 (2004) 149-164
31. Morsanutto A., Berto P., Lopatriello S., Gelisio R., Voinovich D., Cippo P.P., et al. Major complications have an impact on total annual medical cost of diabetes: results of a database analysis. J Diabetes Complications 20 (2006) 163-169
32. Titler M.G., Jensen G.A., Dochterman J.M., Xie X.-J., Kanak M., Reed D., et al. Cost of hospital care for older adults with heart failure: medical, pharmaceutical, and nursing costs. Health Serv Res 43 (2008) 635-655
33. Stewart S., Jenkins A., Buchan S., McGuire A., Capewell S., and McMurray J.J. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail 4 (2002) 361-371
34. Weintraub W.S., Kawabata H., Tran M., L'Italien G.J., and Chen R.S. Influence of co-morbidity on cost of care for heart failure. Am J Cardiol 91 (2003) 1011-1015
35. Gilmer T.P., O'Connor P.J., Rush W.A., Crain A.L., Whitebird R.R., Hanson A.M., et al. Predictors of health care costs in adults with diabetes. Diabetes Care 28 (2005) 59-64
36. Clarke P., Gray A., Legood R., Briggs A., and Holman R. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabetic Med 20 (2003) 442-450
37. Clarke P., Leal J., Kelman C., Smith M., and Colagiuri S. Estimating the cost of complications of diabetes in Australia using administrative health-care data. Value Health 11 (2008) 199-206
38. Gerdtham U.-G., Clarke P., Hayes A., and Gudbjornsdottir S. Estimating the cost of diabetes mellitus-related events from inpatient admissions in Sweden using administrative hospitalization data. Pharmacoeconomics 27 (2009) 81-90
39. Williams R., Van Gaal L., Lucioni C., and Board C.-A. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia 45 (2002) S13-S17
40. Gandra S.R., Lawrence L.W., Parasuraman B.M., Darin R.M., Sherman J.J., and Wall J.L. Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease. J Manage Care Pharmacy 12 (2006) 546-554
41. Agvall B., Borgquist L., Foldevi M., and Dahlstrom U. Cost of heart failure in Swedish primary healthcare. Scand J Primary Health Care 23 (2005) 227-232
42. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
43. O'Brien J.A., Patrick A.R., and Caro J. Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000. Clin Therapeutics 25 (2003) 1017-1038
44. Caro J.J., Ward A.J., and O'Brien J.A. Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care 25 (2002) 476-481
45. software S. Version 9.1. SAS Institute Inc; Cary, NC.
46. Greene W.H. Economic analysis. 4th edition (2000), Prentice-Hall, Inc., Upper Saddle River, NJ
47. Weintraub W.S., Deaton C., Shaw L., Mahoney E., Morris D.C., Saunders C., et al. Can cardiovascular clinical characteristics be identified and outcome models be developed from an in-patient claims database?. Am J Cardiol 84 (1999) 166-169
48. Hannan E.L., Kilburn Jr. H., Lindsey M.L., and Lewis R. Clinical versus administrative data bases for CABG surgery. Does it matter?. Med Care 30 (1992) 892-907
49. Thorpe K.E., and Howard D.H. The rise in spending among Medicare beneficiaries: the role of chronic disease prevalence and changes in treatment intensity. [see comment]. Health Affairs 25 (2006) w378-w388
50. Ware M.G., Flavell C.M., Lewis E.F., Nohria A., Warner-Stevenson L., and Givertz M.M. Heart failure and diabetes: collateral benefit of chronic disease management. Congest Heart Fail 12 (2006) 132-136
51. Hebert P.L., Sisk J.E., Wang J.J., Tuzzio L., Casabianca J.M., Chassin M.R., et al. Cost-effectiveness of nurse-led disease management for heart failure in an ethnically diverse urban community. Ann Intern Med 149 (2008) 540-548
52. McCauley K.M., Bixby M.B., and Naylor M.D. Advanced practice nurse strategies to improve outcomes and reduce cost in elders with heart failure. Dis Manage 9 (2006) 302-310